Gadoteridol, Reference Standards
USP Reference Standards are specified for use in conducting official USP–NF tests and assays. USP also provides Reference Standards specified in the Food Chemicals Codex as well as authentic substances—high-quality chemical samples—as a service to analytical, clinical, pharmaceutical and research laboratories. To confirm accuracy and reproducibility, USP Reference Standards are rigorously tested and evaluated by multiple independent laboratories including USP, commercial, regulatory, and academic labs. USP also provide publicly available, official documentary standards for pharmaceutical ingredients in the USP–NF that link directly with our primary reference standards.
: US Pharmacopea Reference Standard
USP Reference Standards are specified for use in conducting official USP–NF tests and assays. USP also provides Reference Standards specified in the Food Chemicals Codex as well as authentic substances—high-quality chemical samples—as a service to analytical, clinical, pharmaceutical and research laboratories. To confirm accuracy and reproducibility, USP Reference Standards are rigorously tested and evaluated by multiple independent laboratories including USP, commercial, regulatory, and academic labs. USP also provide publicly available, official documentary standards for pharmaceutical ingredients in the USP–NF that link directly with our primary reference standards.
: US Pharmacopea Reference Standard
- Catalog No:
- 1287631.
- 1287642.
- 1287653.
- 1287664.
- Désignation:
- Gadoteridol
- Gadoteridol Related Compound A
- Gadoteridol Related Compound B
- Gadoteridol Related Compound C
- Synonyme(s):
- 10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid
- 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid gadolinium salt
- 1,4,7,10-Tetraaza-11-oxo-bicyclo[8.2.2]tetradecane-4,7-diacetic acid
- N ° CAS.:
- 120066-54-8
- 120041-08-9
- 112188-16-6
- 220182-19-4
Product Family Options
- DésignationNormesType de conditionnementCdt
- GadoteridolUSP reference standardVial500 mg1 * 500 mg462,00 €
Specifications
Cat. No.1287631.DésignationGadoteridolSynonyme(s)N ° CAS.120066-54-8 - Gadoteridol Related Compound AUSP reference standard50 mg1 * 50 mg1 200,00 €
Specifications
Cat. No.1287642.DésignationGadoteridol Related Compound ASynonyme(s)10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acidN ° CAS.120041-08-9 - Gadoteridol Related Compound BUSP reference standardVial50 mg1 * 50 mg1 270,00 €
Specifications
Cat. No.1287653.DésignationGadoteridol Related Compound BSynonyme(s)1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid gadolinium saltN ° CAS.112188-16-6 - Gadoteridol Related Compound CUSP reference standardVial50 mg1 * 50 mg1 140,00 €
Specifications
Cat. No.1287664.DésignationGadoteridol Related Compound CSynonyme(s)1,4,7,10-Tetraaza-11-oxo-bicyclo[8.2.2]tetradecane-4,7-diacetic acidN ° CAS.220182-19-4



